Immix Biopharma, Inc. IMMX Change in Lease Liabilities
Change in Lease Liabilities at other companies
Other financials
Where this comes from
Reported directly by Immix Biopharma, Inc. in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInOperatingLeaseLiability.
The official record: Immix Biopharma, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Immix Biopharma, Inc.'s change in lease liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Immix Biopharma, Inc.'s change in lease liabilities?
- Immix Biopharma, Inc. (IMMX) reported change in lease liabilities of -$35.23K in Q1 2026.
- How has Immix Biopharma, Inc.'s change in lease liabilities changed year-over-year?
- Immix Biopharma, Inc.'s change in lease liabilities decreased by 122.6% year-over-year, from -$15.83K to -$35.23K.
- What does change in lease liabilities mean?
- Cash payments for operating leases reducing the lease liability, partially offset by new lease commencements.